"Moving forward, we expect to announce additional significant news in the coming weeks regarding LymPro, as well as pending additions to our diagnostics division to buttress this business unit for a potential spin-off into a standalone entity."
Additions plural.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links